| 000 | 01760 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515183153.0 | ||
| 264 | 0 | _c20101215 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a1554-8619 | ||
| 024 | 7 |
_a10.4161/hv.5.10.9518 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEinstein, Mark H | |
| 245 | 0 | 0 |
_aComparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years. _h[electronic resource] |
| 260 |
_bHuman vaccines _cOct 2009 |
||
| 300 |
_a705-19 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Neutralizing _xblood |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 |
_aCancer Vaccines _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeutralization Tests |
| 650 | 0 | 4 |
_aPapillomaviridae _xisolation & purification |
| 650 | 0 | 4 |
_aPapillomavirus Infections _xprevention & control |
| 650 | 0 | 4 |
_aPapillomavirus Vaccines _xadverse effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBaron, Mira | |
| 700 | 1 | _aLevin, Myron J | |
| 700 | 1 | _aChatterjee, Archana | |
| 700 | 1 | _aEdwards, Robert P | |
| 700 | 1 | _aZepp, Fred | |
| 700 | 1 | _aCarletti, Isabelle | |
| 700 | 1 | _aDessy, Francis J | |
| 700 | 1 | _aTrofa, Andrew F | |
| 700 | 1 | _aSchuind, Anne | |
| 700 | 1 | _aDubin, Gary | |
| 773 | 0 |
_tHuman vaccines _gvol. 5 _gno. 10 _gp. 705-19 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/hv.5.10.9518 _zAvailable from publisher's website |
| 999 |
_c19087748 _d19087748 |
||